BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Bevacizumab
1
Vascular endothelial growth factor pathway’s influence on bevacizumab efficacy in metastatic colorectal cancer treatment
10/25/2024 10:27:31 AM | Browse: 110 | Download: 481
2
Efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer according to programmed cell death ligand 1
8/8/2024 4:58:16 AM | Browse: 182 | Download: 687
3
Synaptophysin-like 2 expression correlates with lymph node metastasis and poor prognosis in colorectal cancer patients
11/15/2022 10:19:35 AM | Browse: 583 | Download: 2045
4
Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review
7/14/2022 8:05:03 AM | Browse: 656 | Download: 1866
5
Arteriovenous thrombotic events in a patient with advanced lung cancer following bevacizumab plus chemotherapy: A case report
6/24/2022 9:00:24 AM | Browse: 554 | Download: 1568
6
Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice
9/22/2021 8:09:41 AM | Browse: 641 | Download: 1025
7
Colorectal cancer metastatic to the breast: A case report
9/10/2020 5:57:28 AM | Browse: 901 | Download: 1726
8
Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: A case report
7/20/2020 2:28:50 AM | Browse: 900 | Download: 2202
9
Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports
4/28/2020 8:04:31 AM | Browse: 984 | Download: 1795
10
Primary tumor location and survival in colorectal cancer: A retrospective cohort study
4/15/2020 12:00:00 PM | Browse: 931 | Download: 1948
11
Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy
2/22/2019 4:33:37 AM | Browse: 1178 | Download: 1415
12
Tertiary stent-in-stent for obstructing colorectal cancer: A case report and literature review
1/16/2019 8:39:45 AM | Browse: 993 | Download: 2005
13
Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors
12/14/2018 10:51:23 AM | Browse: 992 | Download: 1463
14
CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer
11/13/2018 8:04:45 AM | Browse: 1215 | Download: 2007
15
Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia
12/20/2016 1:38:00 PM | Browse: 1341 | Download: 2355
16
Role of targeted therapy in metastatic colorectal cancer
9/12/2016 10:43:00 AM | Browse: 1241 | Download: 2163
17
Treatment of diabetic retinopathy: Recent advances and unresolved challenges
8/23/2016 8:55:00 AM | Browse: 1267 | Download: 2167
18
Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer
7/15/2016 3:38:00 PM | Browse: 1413 | Download: 2317
19
Molecular pathogenesis of glioblastoma multiforme: Nuances, obstacles, and implications for treatment
9/30/2015 4:28:00 PM | Browse: 1484 | Download: 2094
20
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study
6/20/2015 5:38:00 PM | Browse: 1650 | Download: 3256
21
Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab
5/13/2015 10:38:00 AM | Browse: 1294 | Download: 2759
22
Value of bevacizumab in treatment of colorectal cancer: A meta-analysis
4/27/2015 4:29:00 PM | Browse: 1372 | Download: 2081
23
Targeted therapy in first line treatment of RAS wild type colorectal cancer
3/16/2015 6:04:00 PM | Browse: 1279 | Download: 1769
24
FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma
2/11/2015 4:38:00 PM | Browse: 1200 | Download: 1395
25
Combinations of vascular endothelial growth factor pathway inhibitors with metronomic chemotherapy: Rational and current status
11/19/2014 2:49:00 PM | Browse: 1289 | Download: 1638
26
Bevacizumab maintenance in metastatic colorectal cancer: How long?
11/10/2014 12:19:00 PM | Browse: 1230 | Download: 1819
27
Preoperative intravitreal bevacizumab and silicone oil tamponade for vitrectomy in diabetic retinopathy
10/20/2014 9:54:00 AM | Browse: 1298 | Download: 1999
28
Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases
9/16/2014 6:10:00 PM | Browse: 1345 | Download: 1325
29
Role of bevacizumab in colorectal cancer growth and its adverse effects: A review
9/15/2014 8:54:00 PM | Browse: 1388 | Download: 1451
30
Anti-angiogenic therapies for metastatic colorectal cancer: Current and future perspectives
9/11/2014 8:40:00 PM | Browse: 1214 | Download: 1756
31
Meta-regression of treatments for metastatic colorectal cancer: Quantifying incremental benefit from 2000 to 2012
9/3/2014 11:44:00 AM | Browse: 1308 | Download: 1778
32
Bevacizumab for the management of diabetic macular edema
9/1/2014 3:42:00 PM | Browse: 1330 | Download: 1335
33
Ranibizumab in diabetic macular edema
9/1/2014 2:50:00 PM | Browse: 1300 | Download: 1477
34
Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer
9/1/2014 10:30:00 AM | Browse: 1488 | Download: 1193
35
Targeting receptor tyrosine kinases in gastric cancer
8/28/2014 5:50:00 PM | Browse: 1302 | Download: 1535
36
Bevacizumab in the pre-operative treatment of locally advanced rectal cancer: A systematic review
8/26/2014 5:16:00 PM | Browse: 1356 | Download: 1174
37
Advances and new perspectives in the treatment of metastatic colon cancer
8/26/2014 4:37:00 PM | Browse: 1395 | Download: 1743
38
Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer
8/26/2014 4:36:00 PM | Browse: 1384 | Download: 1329